0001828649-23-000005.txt : 20230814
0001828649-23-000005.hdr.sgml : 20230814
20230814115933
ACCESSION NUMBER: 0001828649-23-000005
CONFORMED SUBMISSION TYPE: C-U
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bioverge, Inc.
CENTRAL INDEX KEY: 0001828649
IRS NUMBER: 822592905
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: C-U
SEC ACT: 1933 Act
SEC FILE NUMBER: 020-32267
FILM NUMBER: 231167730
BUSINESS ADDRESS:
STREET 1: 447 SUTTER ST. STE 405
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
BUSINESS PHONE: 8664151001
MAIL ADDRESS:
STREET 1: 447 SUTTER ST
STREET 2: STE 405
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
C-U
1
primary_doc.xml
C-U
0001828649
XXXXXXXX
020-32267
LIVE
false
false
false
The Offering closed successfully on 8/8/2023, having received investment commitments of $138,007, although a final accounting has not taken place.
Bioverge, Inc.
Corporation
DE
08-17-2017
447 SUTTER ST
STE 405
SAN FRANCISCO
CA
94108
https://bioverge.com/
N
OpenDeal Portal LLC
0001751525
007-00167
283874
At the conclusion of the Offering, the Issuer shall pay the Intermediary a fee of six percent (6%) of the dollar amount raised in the Offering.
The Intermediary will also receive compensation in the form of securities equal to two percent (2%) of the total number of the securities sold in the Offering.
Other
Crowd SAFE (Simple Agreement for Future Equity)
25000
1.00000
Arbitrary
25000.00
Y
Other
Other: At the Intermediary's discretion
1235000.00
08-07-2023
2.00
567769.00
751759.00
324314.00
487668.00
0.00
0.00
52668.00
178120.00
0.00
0.00
247786.00
251720.00
49972.00
26101.00
0.00
0.00
-406203.00
-591903.00
AL
AK
AZ
AR
CA
CO
CT
DE
DC
FL
GA
HI
ID
IL
IN
IA
KS
KY
LA
ME
MD
MA
MI
MN
MS
MO
MT
NE
NV
NH
NJ
NM
NY
NC
ND
OH
OK
OR
PA
PR
RI
SC
SD
TN
TX
UT
VT
VA
WA
WV
WI
WY
Bioverge, Inc.
Neil Littman
President and CEO
Neil Littman
President and CEO
08-14-2023
Richard Gibb
COO
08-14-2023